ClinConnect ClinConnect Logo
Search / Trial NCT06907420

40 Hz Visual Stimulation as an Intervention in Schizophrenia

Launched by TECHNICAL UNIVERSITY OF MUNICH · Mar 26, 2025

Trial Information

Current as of September 04, 2025

Recruiting

Keywords

Gamma 40 Hz Schizophrenia Visual Stimulation Eeg Neuromodulation Flicker Sleep Negative Symptoms

ClinConnect Summary

This clinical trial is studying a new way to help people with schizophrenia, particularly those who experience negative symptoms like difficulty thinking clearly or feeling low. Researchers want to see if a type of brain stimulation using 40 Hz visual patterns can improve these symptoms. The study will involve at least ten patients diagnosed with schizophrenia or schizoaffective disorder who have these symptoms. Participants will receive this visual stimulation for one hour a day over five days, during which they will be encouraged to relax or fall asleep. There will also be a separate group of patients who will continue their usual treatment without the stimulation.

To be eligible for the trial, participants must be at least 18 years old and have a medical diagnosis of schizophrenia or schizoaffective disorder. However, those with a history of seizures, acute suicidal thoughts, certain other mental health conditions, or specific vision problems will not be able to participate. Before and after the stimulation sessions, researchers will assess participants' brain activity and their cognitive and emotional well-being through various tests. The findings from this study could help determine if this type of visual stimulation is a safe and helpful addition to current treatments for schizophrenia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Medical diagnosis of schizophrenia (F20) or schizoaffective disorder (F25)
  • Exclusion Criteria:
  • Age \< 18 years
  • Any history of seizures
  • Acute suicidality assessed with the Columbia-Suicide Severity Rating Scale (C-SSRS; Brent et al., 2008)
  • Any other relevant axis 1 disorder
  • Red-green colour blindness or current ocular disease
  • Alcohol, cannabis, or illicit drug addiction within the last 3 months

About Technical University Of Munich

The Technical University of Munich (TUM) is a leading research institution in Germany, renowned for its commitment to excellence in education, innovation, and technology transfer. With a strong emphasis on interdisciplinary collaboration, TUM fosters advancements in various fields, including medicine and life sciences. The university actively engages in clinical research, aiming to translate scientific discoveries into practical applications that improve patient outcomes. Through its state-of-the-art facilities and a network of partnerships with hospitals and industry, TUM is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and contribute significantly to the advancement of healthcare.

Locations

Munich, Bavaria, Germany

Patients applied

0 patients applied

Trial Officials

Ulrike Vogelmann, MD

Principal Investigator

TUM School of Medicine and Health, Department of Psychiatry and Psychotherapy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported